Abercrombie george b - direct investment history in Tranzyme inc

Filed on 2012-08-09 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001104659-12-056656.txt Sec File: edgar/data/1485939/0001104659-12-056656-index.htm

2012-08-07 Abercrombie George B (CIK 1485939) through Direct

Invested in Tranzyme Inc bought 31835 shares at $0 remaining shares owned 31835

Stock Option Right To Buy Tranzyme Inc Tzym exercise price 4.24 has valueitem expiration due date 2022-08-07 underlying security shares 31835 underlying security title Common Stock

f1 option to purchase common stock granted by the issuer pursuant to the issuer's 2011 stock option and incentive plan, qualified under rule 16b-3(d).
f2 this option may be exercised with respect to 20% of the shares underlying the option on august 7, 2012 (the "vesting commencement date") and 20% of the shares subject to the option when the reporting person completes each calendar quarter of continuous service following the vesting commencement date.


Filed on 2011-10-20 by Abercrombie George B SEC CIK 1485939 Form 4/a

Accession 0001104659-11-057024.txt Sec File: edgar/data/1485939/0001104659-11-057024-index.htm

2011-10-18 Abercrombie George B (CIK 1485939) through Direct

Invested in Tranzyme Inc bought 25000 shares at $0 remaining shares owned 25000

Stock Option Right To Buy Tranzyme Inc Tzym exercise price 2.97 has valueitem expiration due date 2021-10-18 underlying security shares 25000 underlying security title Common Stock

f1 option to purchase common stock granted by the issuer pursuant to the issuer's 2011 stock option and incentive plan, qualified under rule 16b-3(d).
f2 20% of the shares are vested and exercisable as of october 18, 2011, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 4 quarters thereafter.
f3 the reporting person's original form 4 incorrectly stated that the expiration date for the stock option (right to buy) is october 18, 2011. the correct expiration date is october 18, 2021.


Filed on 2011-10-20 by Abercrombie George B SEC CIK 1485939 Form 4

Accession 0001104659-11-057006.txt Sec File: edgar/data/1485939/0001104659-11-057006-index.htm

2011-10-18 Abercrombie George B (CIK 1485939) through Direct

Invested in Tranzyme Inc bought 25000 shares at $0 remaining shares owned 25000

Stock Option Right To Buy Tranzyme Inc Tzym exercise price 2.97 has valueitem expiration due date 2011-10-18 underlying security shares 25000 underlying security title Common Stock

f1 option to purchase common stock granted by the issuer pursuant to the issuer's 2011 stock option and incentive plan, qualified under rule 16b-3(d).
f2 20% of the shares are vested and exercisable as of october 18, 2011, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 4 quarters thereafter.